Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C

Transplantation

Volumn 80, Issue 4, 2005, Pages 448-456

  Rayhill, Stephen C ^a,c   Kirby, Patricia A ^a   Voigt, Michael D ^a   La Brecque, Douglas R ^a   Lutz, Charles T ^a   Katz, Daniel A ^a   Mitros, Frank A ^a   Kalil, Roberta S ^a   Miller, Rachel A ^a   Stolpen, Alan H ^a   Heisey, Dennis ^b   Wu, You Min ^a   Schmidt, Warren N ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cirrhosis; Cryoglobulinemia; Hepatitis C virus; Liver transplantation

Indexed keywords

ALPHA INTERFERON; CALCINEURIN INHIBITOR; CRYOGLOBULIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; COHORT ANALYSIS; DEATH; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT VIRUS INFECTION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; VIRUS LOAD;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CRYOGLOBULINS; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, HOMOLOGOUS;

EID: 23944489799     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000164826.84041.F0     Document Type: Article

References (48)

1. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. Hepatology 2001; 35: 666.
2. Feray C, Caccamo L, Alexander GJM, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology 1999; 117: 619.
3. Gordon FD, Poterucha JJ, Germer J, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63: 1419.
4. Papatheodoridis GV, Davies S, Dhillon AP, et al. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001; 72: 412.
5. Sanchez-Fueyo A, Restrepo JC, Quinto L, et al. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation 2002; 73: 56.
6. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490.
7. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291.
8. Schmidt WN, Stapleton JT, LaBrecque DR, et al. Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology. Hepatology 2000; 31: 737.
9. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia. Clin Exp Rheum 1991; 9: 621.
10. Pascual M, Perrin L, Giostra E, et al. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569.
11. Kayali Z, Buckwold VE, Zimmerman B, et al. Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis. Hepatology 2002; 36: 978.
12. Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins: A report of 86 cases. Am J Med 1974; 57: 775.
13. Batts KP, Ludwig J. Chronic hepatitis: An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409.
14. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513.
15. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991; 13: 372.
16. Schmidt WN, Wu P, Cederna J, et al. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. J Infect Dis 1997; 176: 27.
17. Dammacco F, Sansonno D, Piccoli C, et al. The cryoglobulins: An overview. Eur J Clin Invest 2001; 31: 628.
18. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823.
19. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000; 32: 1125.
20. Rayhill SC Schmidt WN, Voigt M, et al. Cryoglobulinemia does not produce worse renal function in liver transplant recipients with hepatitis C. Am J Transplant 2002; 2: 427.
21. Dammacco F, Sansonno D. Antibodies to hepatitis-C virus in essential mixed cryoglobulinemia. Clin Exp Immunol 1992; 87: 352.
22. Adinolfi LE, Utili R, Zampino R, et al. Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia. Eur J Gastroenterol Hepatol 1997; 9: 1067.
23. Cresta P, Musset L, Cacoub P, et al. Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut 1999; 45: 122.
24. Adinolfi LE, Utili R, Attanasio V, et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: A prospective study. Ital J Gastroenterol 1996; 28: 1.
25. Akriviadis EA, Xanthakis I, Navrozidou C, et al. Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha. J Clin Gastroenterol 1997; 25: 612.
26. Cicardi M, Cesana B, Del Ninno E, et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepatitis 2000; 7: 138.
27. Fayyazi A, Schott P, Hartmann H, et al. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia. Z Gastroenterol 1997; 35: 921.
28. Hartmann H, Schott P, Polzien F, et al. Cryoglobulinemia in chronic hepatitis C virus infection: Prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. J Gastroenterol 1995; 33: 643.
29. Horcajada JP, Garcia-Bengoechea M, Cilia G, et al. Mixed cryoglobulinemia in patients with chronic hepatitis C infection: Prevalence, significance and relationship with different viral genotypes. Ann Med 1999; 31: 352.
30. Hwang SJ, Lee SD, Li CP, et al. Clinical study of cryoglobulinemia in Chinese patients with chronic hepatitis C. J Gastroenterol Hepatol 1997; 12: 513.
31. Tanaka K, Aiyama T, Imai J, et al. Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 1995; 90: 1847.
32. Bilzer M, Gerbes AL. Preservation injury of the liver: Mechanisms and novel therapeutic strategies. J Hepatol 2000; 32: 508.
33. Testa G, Crippin JS, Netto GJ, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553.
34. Liang TJ, Rehermann B, Seeff LB, et al. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000; 132: 296.
35. Nelson DR. The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2004; 5: 931.
36. Newkirk MM. Rheumatoid factors: Host resistance or autoimmunity? Clin Immunol 2002; 104: 1.
37. Cacciarelli TV, Martinez OM, Gish RG, et al. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa. Hepatology 1996; 24: 6.
38. Abrahamian GA, Cosimi AB, Farrell ML, et al. Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation. Liver Transpl 2000; 6: 185.
39. Gane EJ, Maertens G, Ducatteeuw A, et al. Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation. Transplantation 1999; 67: 78.
40. Gournay J, Ferrell LD, Roberts JP, et al. Cryoglobulinemia presenting after liver transplantation. Gastroenterology 1996; 110: 265.
41. Rahamimov R, Ilan Y, Eid A, et al. Hepatitis C-associated cryoglobulinemia after liver-transplantation. Transplantation 1995; 60: 1050.
42. Safadi R, Shouval D, Eid A, et al. Hepatitis-C-associated cryoglobulinemia after liver transplantation. Transplant Proc 1997; 29: 2684.
43. Burak KW, Kremers WK, Batts KP, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002; 8; 362.
44. Herrero JI, de la Pena A, Quiroga J, et al. Risk factors for recurrence of hepatitis C after liver transplantation. Liver Transplant Surg 1998; 4: 265.
45. Gane EJ, Naoumov NV, Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 335: 522.
46. Ghobrial RM, Farmer DG, Baquerizo A, et al. Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg 1999; 229: 824.
47. Gane EJ, Naoumov NV, Qian KP, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167.
48. Freeman RB, Tran S, Lee YM, et al. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 1996; 61: 542.